BEGIN:VCALENDAR
PRODID:-//Pixl8//Eventfolio//EN
VERSION:2.0
X-WR-TIMEZONE:Europe/Brussels
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:Europe/Brussels
LAST-MODIFIED:20260306T231828Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Europe/Brussels
X-LIC-LOCATION:Europe/Brussels
BEGIN:DAYLIGHT
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
DTSTART:19700329T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
DTSTART:19701025T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20250710T150000
DTEND;TZID=Europe/Brussels:20250710T155000
DTSTAMP:20260411T081540Z
UID:{ACE3548A-D880-4B3D-AE525F82338FF9FF}
LOCATION:Online
SUMMARY:Real-world evidence for Oncology innovation in Europe
DESCRIPTION:Real-world evidence is becoming an indispensable tool for pharma companies. The availability of digital health tools, electronic health records  and advances in data analytics have facilitated the large-scale collection of real-world data, enabling a wealth of insights into patient outcomes and clinical effectiveness and safety of medicines beyond clinical trials.\n
 \n
 This Financial Times webinar will bring together global biopharma companies, health regulators, health technology assessors, and other industry experts to explore the evolving landscape for real-world evidence (RWE) in Europe, and how the regional and global evidence base can be improved and harmonised to revolutionise healthcare decision-making, drug development and patient care.\n
 \n
 Event details: https://www.lisah.org/events/real-world-evidence-for-oncology-innovation-in-europe.html
PRIORITY:1
END:VEVENT
END:VCALENDAR